{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:13:12Z","timestamp":1791184392996,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T00:00:00Z","timestamp":1291075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00216-010-4455-4","type":"journal-article","created":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T10:43:32Z","timestamp":1291027412000},"page":"543-551","source":"Crossref","is-referenced-by-count":11,"title":["Screening for benfluorex and its major urinary metabolites in routine doping controls"],"prefix":"10.1007","volume":"401","author":[{"given":"Mario","family":"Thevis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Sigmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Gougoulidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Beuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Schl\u00f6rer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Kwiatkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Pokrywka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Sch\u00e4nzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,30]]},"reference":[{"key":"4455_CR1","unstructured":"Boulogene LB, Hugon P, and Le Douarec J-C (1971) in United States Patent Office, Science Union et Cie Societe Francaise de Recherche Medicale Suresnes, United States"},{"key":"4455_CR2","first-page":"140","volume-title":"Pharmaceutical manufacturing encyclopedia","author":"M Sittig","year":"1988","unstructured":"Sittig M (1988) Pharmaceutical manufacturing encyclopedia. Noyes, New Jersey, p 140"},{"key":"4455_CR3","doi-asserted-by":"crossref","unstructured":"Brindley DN (1993) \u201cMechanisms for the effects of benfluorex on the obese\u2013diabetic\u2013dyslipidemic syndrome\u201d, Diabetes Metab Rev 9 Suppl 1, 51S","DOI":"10.1002\/dmr.5610090509"},{"key":"4455_CR4","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1183\/09031936.00086308","volume":"33","author":"K Boutet","year":"2009","unstructured":"Boutet K, Frachon I, Jobic Y, Gut-Gobert C, Leroyer C, Carlhant-Kowalski D, Sitbon O, Simonneau G, Humbert M (2009) Fenfluramine-like cardiovascular side-effects of benfluorex. Eur Respir J 33:684","journal-title":"Eur Respir J"},{"key":"4455_CR5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1472-8206.2006.00441.x","volume":"20","author":"P Noize","year":"2006","unstructured":"Noize P, Sauer M, Bruneval P, Moreau M, Pathak A, Bagheri H, Montastruc JL (2006) Valvular heart disease in a patient taking benfluorex. Fundam Clin Pharmacol 20:577","journal-title":"Fundam Clin Pharmacol"},{"key":"4455_CR6","unstructured":"EMEA (2009) European Union, London"},{"key":"4455_CR7","unstructured":"TAS-CAS (2009) Tribunal Arbitral du Sport\u2014Court of Arbitration for Sport, Lausanne"},{"key":"4455_CR8","unstructured":"World Anti-Doping Agency (2010) \u201cThe 2010 Prohibited List\u201d, http:\/\/www.wada-ama.org\/Documents\/World_Anti-Doping_Program\/WADP-Prohibited-list\/WADA_Prohibited_List_2010_EN.pdf , 14-01-2010"},{"key":"4455_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/dta.9","volume":"1","author":"M Thevis","year":"2009","unstructured":"Thevis M, Kuuranne T, Geyer H, Sch\u00e4nzer W (2009) Annual banned-substance review: the Prohibited List 2008\u2014analytical approaches in human sports drug testing. Drug Test Anal 1:4","journal-title":"Drug Test Anal"},{"key":"4455_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/dta.128","volume":"2","author":"M Thevis","year":"2010","unstructured":"Thevis M, Kuuranne T, Geyer H, Sch\u00e4nzer W (2010) Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal 2:149","journal-title":"Drug Test Anal"},{"key":"4455_CR11","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.2042-7158.1971.tb09899.x","volume":"23","author":"AH Beckett","year":"1971","unstructured":"Beckett AH, Shenoy EV, Brookes LG (1971) Determination of N-(2-benzoyloxyethyl)-norfenfluramine (JP 992) and its metabolites in urine. J Pharm Pharmacol 23:950","journal-title":"J Pharm Pharmacol"},{"key":"4455_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.2042-7158.1972.tb08987.x","volume":"24","author":"AH Beckett","year":"1972","unstructured":"Beckett AH, Shenoy EV, Brookes LG (1972) The absorption, metabolism and elimination of (plus minus)-N-(2-benzoyloxyethyl)norfenfluramine (JP992) in man. J Pharm Pharmacol 24:281","journal-title":"J Pharm Pharmacol"},{"key":"4455_CR13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0009-2797(95)03624-U","volume":"97","author":"T Orsiere","year":"1995","unstructured":"Orsiere T, Chauvet M, Dell\u2019Amico M, Lafont H, Bourdeaux M (1995) In vitro influence of benfluorex and its main metabolites on rat liver microsomal membrane properties. Chem Biol Interact 97:297","journal-title":"Chem Biol Interact"},{"key":"4455_CR14","unstructured":"Nolteernsting E, Opfermann G, and Donike M (1996) In recent advances in doping analysis Donike M, Geyer H, Gotzmann A, and Mareck-Engelke U (eds.), Sport & Buch Strauss, Cologne Vol. 3:pp. 369"},{"key":"4455_CR15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0021-9673(01)96571-9","volume":"52","author":"M Donike","year":"1970","unstructured":"Donike M, Jaenicke L, Stratmann D, Hollmann W (1970) Gas chromatographic detection of nitrogen-containing drugs in aqueous solutions by means of the nitrogen detector. J Chromatogr 52:237","journal-title":"J Chromatogr"},{"key":"4455_CR16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/BF02279446","volume":"3","author":"M Donike","year":"1970","unstructured":"Donike M (1970) Temperature programmed gas chromatographic analysis of nitrogen-containing drugs: the reproducibility of retention times (I). Chromatographia 3:422","journal-title":"Chromatographia"},{"key":"4455_CR17","doi-asserted-by":"crossref","unstructured":"Kromidas A (1999) Validierung in der Analytik. Wiley, Weinheim","DOI":"10.1002\/9783527624911"},{"key":"4455_CR18","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1044-0305(03)00574-9","volume":"14","author":"R Dams","year":"2003","unstructured":"Dams R, Huestis MA, Lambert WE, Murphy CM (2003) Matrix effect in bio-analysis of illicit drugs with LC-MS\/MS: influence of ionization type, sample preparation, and biofluid. J Am Soc Mass Spectrom 14:1290","journal-title":"J Am Soc Mass Spectrom"},{"key":"4455_CR19","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","volume":"75","author":"BK Matuszewski","year":"2003","unstructured":"Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS. Anal Chem 75:3019","journal-title":"Anal Chem"},{"key":"4455_CR20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ecl.2009.10.011","volume":"39","author":"M Thevis","year":"2010","unstructured":"Thevis M, Sigmund G, Geyer H, Sch\u00e4nzer W (2010) Stimulants and doping in sport. Endocrinol Metab Clin North Am 39:89","journal-title":"Endocrinol Metab Clin North Am"},{"key":"4455_CR21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-4347(96)00276-9","volume":"687","author":"P Hemmersbach","year":"1996","unstructured":"Hemmersbach P, de la Torre R (1996) Stimulants, narcotics and \u03b2-blockers: 25\u00a0years of development in analytical techniques for doping control. J Chromatogr B 687:221","journal-title":"J Chromatogr B"},{"key":"4455_CR22","unstructured":"World Anti-Doping Agency (2008) \u201cMinimum required performance levels for detection of prohibited substances\u201d, http:\/\/www.wada-ama.org\/rtecontent\/document\/MINIMUM_REQUIRED_PERFORMANCE_LEVELS_TD_v1_0_January_2009.pdf , 24-11-2008"},{"key":"4455_CR23","unstructured":"Beckett AH, and Brookes LG (1967) \u201cThe absorption and urinary excretion in man of fenfluramine and its main metabolite\u201d, J Pharm Pharmacol 19: Suppl 42S"},{"key":"4455_CR24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0378-4347(91)80584-Y","volume":"562","author":"R Brownsill","year":"1991","unstructured":"Brownsill R, Wallace D, Taylor A, Campbell B (1991) Study of human urinary metabolism of fenfluramine using gas chromatography-mass spectrometry. J Chromatogr 562:267","journal-title":"J Chromatogr"},{"key":"4455_CR25","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3109\/00498259209053154","volume":"22","author":"NC Marchant","year":"1992","unstructured":"Marchant NC, Breen MA, Wallace D, Bass S, Taylor AR, Ings RM, Campbell DB, Williams J (1992) Comparative biodisposition and metabolism of 14C-(+\/\u2212)-fenfluramine in mouse, rat, dog and man. Xenobiotica 22:1251","journal-title":"Xenobiotica"},{"key":"4455_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1387-3806(00)00166-4","volume":"199","author":"S Hammerum","year":"2000","unstructured":"Hammerum S, Henriksen T (2000) The rearrangement and simple cleavage of metastable octanamine radical cations. Int J Mass Spectrom 199:79","journal-title":"Int J Mass Spectrom"},{"key":"4455_CR27","doi-asserted-by":"crossref","first-page":"12046","DOI":"10.1021\/jp0550614","volume":"109","author":"S Hammerum","year":"2005","unstructured":"Hammerum S, Nielsen CB (2005) Intramolecular hydrogen bonding and hydrogen atom abstraction in gas-phase aliphatic amine radical cations. J Phys Chem A 109:12046","journal-title":"J Phys Chem A"},{"key":"4455_CR28","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1021\/ja043481l","volume":"127","author":"S Hammerum","year":"2005","unstructured":"Hammerum S, Norrman K, Solling TI, Andersen PE, Jensen LB, Vulpius T (2005) Competing simple cleavage reactions: the elimination of alkyl radicals from amine radical cations. J Am Chem Soc 127:6466","journal-title":"J Am Chem Soc"},{"key":"4455_CR29","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/ac60190a025","volume":"34","author":"RS Gohlke","year":"1962","unstructured":"Gohlke RS, McLafferty FW (1962) Mass spectrometric analysis\u2014aliphatic amines. Anal Chem 34:1281","journal-title":"Anal Chem"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-010-4455-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-010-4455-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-010-4455-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T16:48:59Z","timestamp":1559839739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-010-4455-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,30]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["4455"],"URL":"https:\/\/doi.org\/10.1007\/s00216-010-4455-4","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,30]]}}}